Clinical Trials
5 trialsNCT02158507 2026-01-22
Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer
University of Alabama at Birmingham
Phase NA Completed
NCT01636908 2021-04-15
ICK
Amsterdam UMC, location VUmc
Phase NA Completed
NCT01190241 2020-11-20
TSAP
Amsterdam UMC, location VUmc
Phase NA Terminated
NCT00555152 2018-04-20
Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ
National Cancer Institute (NCI)
Phase NA Completed
NCT00857714 2015-07-08
Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast
Indiana University
Phase NA Terminated